Enda Kenny

USPTO Granted Patents = 7 (Patent Applications = 2)

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 4.3

ph-index = 1

Forward Citations = 38(Granted Patents)

Location History:

Dublin, IE (2021)
Killiney, IE (2014 - 2024)
Kilkenny, IE (2024)

Company Filing History:

Years Active: 2014-2025

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12390495 - Micronized eggshell membrane particles and the use thereof to promote the healing of wounds (2025-08-19),

2. 11992508 - Micronized eggshell membrane particles and the use thereof to promote the healing of wounds (2024-05-28),

3. 11980655 - Methods of treatment with stable liquid formulations of glucagon-like peptide 1 or analogues thereof (2024-05-14),

4. 11058748 - Stable liquid formulations of glucagon-like peptide 1 or analogues thereof (2021-07-13),

5. 11045578 - Tissue engineering scaffolds comprising particulate egg shell membrane (2021-06-29),

6. 10932952 - Dry biocompatible disintegratable films for delivering particulate egg shell membrane to a wound (2021-03-02),

7. 8642548 - Val (8) GLP-1 composition and method for treating functional dyspepsia and/or irritable bowel syndrome (2014-02-04),

Title: Enda Kenny: Innovator in Wound Healing Technologies

Introduction

Enda Kenny is a notable inventor based in Dublin, Ireland, recognized for his contributions to the field of medical technology. With a total of seven patents to his name, he has made significant strides in developing innovative solutions for wound healing.

Latest Patents

One of Kenny's latest patents focuses on micronized eggshell membrane (ESM) particles and their application in promoting the healing of wounds. This invention provides a particle consisting essentially of micronized ESM with a mean particle diameter of less than 100 μm. It is designed for use in treating chronic wounds that may exhibit inappropriate levels of matrix-metalloproteinase (MMP) activity or excessive inflammatory responses. The patent also includes pharmaceutical compositions, wound dressings, and implantable medical devices that incorporate these micronized ESM-containing particles, along with methods for their manufacturing.

Career Highlights

Throughout his career, Enda Kenny has worked with various companies, including Biovotec AS and Rose Pharma LLC. His work has focused on advancing medical technologies that address critical health challenges, particularly in wound care.

Collaborations

Kenny has collaborated with notable professionals in his field, including Ralf Schmidt and Henri-Pierre Suso. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Enda Kenny's work in the field of wound healing technologies exemplifies the impact of innovation on healthcare. His patents and collaborations highlight his commitment to improving patient outcomes through advanced medical solutions.

This text is generated by artificial intelligence and may not be accurate.